Study Stopped
Researcher left institution
Effect of Cumulative Chloride Dose on Development of Acute Kidney Injury in Critically Ill Children
Retrospective Investigation of Chloride Dosing and Its Effect on Acute Kidney Injury
1 other identifier
observational
N/A
1 country
1
Brief Summary
The investigators would like to investigate the effect of chloride dosing on the development of acute kidney injury in critically ill patients. The investigators hypothesis is that administering intravenous fluids with higher chloride content are more likely to lead to acute kidney injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 19, 2013
CompletedFirst Posted
Study publicly available on registry
July 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedAugust 22, 2022
August 1, 2022
1.9 years
July 19, 2013
August 17, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Acute Kidney Injury
or sooner if death or discharged
7 days
Secondary Outcomes (4)
PICU length of stay
7 days
Hospital length of stay
7 days
Number of ventilator days
7 days
Mortality
7 days
Study Arms (2)
High Chloride Dose
Patients receiving high dosing of chloride
Low Chloride Dose
Patients receiving low dosing of chloride
Eligibility Criteria
Children \< 18 yo admitted to the Pediatric Intensive Care Unit at Lucile Packard Children's Hospital with admitting diagnosis of sepsis, respiratory failure, or liver failure
You may qualify if:
- age less than 18 years
- PICU admitting diagnosis of sepsis, respiratory failure, or hepatic failure.
You may not qualify if:
- hyponatremia or hypernatremia at PICU admission
- preexisting diagnosis of End-stage renal disease or renal transplant
- presence of neurologic comorbidities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lucile Packard Children's Hospital
Palo Alto, California, 94303, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Weiwen V Shih, MD
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2013
First Posted
July 11, 2014
Study Start
July 1, 2013
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
August 22, 2022
Record last verified: 2022-08